BioMed Valley Discoveries
is a Private company. David M Chao is the President & CEO of BioMed Valley Discoveries and has an approval rating of 70 from Owler members. BioMed Valley Discoveries has 6 followers on Owler.BioMed Valley Discoveries
is a Private company. David M Chao is the President & CEO of BioMed Valley Discoveries and has an approval rating of 70 from Owler members. BioMed Valley Discoveries has 6 followers on Owler.
News
Aug 13, 2024
GlobalNewswire
Press Release: BioMed Valley Discoveries : Biomed Valley Discoveries Announces First Patient Dosed in Phase 2 Study of Its First-in-Class ERK 1/2 Inhibitor Ulixertinib in People with Histiocytosis
Sep 13, 2022
Clinical Trials Arena
BioMed Valley Discoveries: BioMed doses first subject in Phase II gastrointestinal malignancy trial
Mar 22, 2022
Newswise
Press Release: BioMed Valley Discoveries : Biomed Valley Discoveries Announces Poster Presentations on Ulixertinib (BVD-523) at the AACR Annual Meeting 2022
Aug 04, 2020
Clinical Lab Products
BioMed Valley Discoveries: Strata Oncology, BioMed Valley Partner for ERK Inhibitor Study
Oct 04, 2017
The Business Journals: Kansas City
BioMed Valley Discoveries: KC biotech firm develops new drug with promise for fighting multiple cancers
Aug 14, 2014
KANSAS CITY BUSINESS JOURNAL
BioMed Valley Discoveries: Stowers advances treatment of inoperable tumors
Aug 13, 2014
NEWSWISE
Press Release: BioMed Valley Discoveries : Bacterial Biosurgery Shows Promise for Reducing the Size of Inoperable Tumors